Stories about Johnson & Johnson
One document One document
AVECTAS Leads EUR7.23 million Consortium Awarded Part Funding From Disruptive Technologies Innovation Fund
Dublin (ots/PRNewswire) - Funding to develop high throughput cell engineering technology to manufacture 'off the shelf' cell therapies. Project, led by Avectas in partnership with Bluebridge Technologies and National Institute for Bioprocessing Research and Training (NIBRT), would support Ireland's goal of being at ...
Origenis founds biotech company Neuron23 in Silicon Valley together with star investor Kleiner PerkinsOne document
One document One document One document
KOPIE VON: Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-upsOne document
Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-upsOne document
Dublin (ots/PRNewswire) - - Avectas announces residency at Johnson & Johnson Innovation - JLABS @ Toronto, central to the Canadian bio-hub. - Jessica Schwaber, PhD appointed Scientific Director of Cell and Gene Therapy. Avectas, a cell engineering technology business, is pleased to announce it has been accepted to become a resident at Johnson & Johnson Innovation - JLABS @ Toronto. JLABS @ Toronto is a 40,000 square-foot ...
Breakthrough 2020: ArisGlobal Announces Virtual Event for Life Sciences R&D Professionals Set for October 2020
Miami, Fla. (ots/PRNewswire) - The two-day online summit features keynotes from leading voices in life sciences, panel discussions, and product innovation showcases throughout the event ArisGlobal, the leading provider of a SaaS platform that automates core product development functions for over 300 global life ...
Final Phase II Results for UCB's Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances
Brussels (ots/PRNewswire) - - Phase II data demonstrated clinically meaningful platelet count increases with meaningful decreases in IgG concentration - Rozanolixizumab's subcutaneous route of administration shows potential to deliver targeted individualized patient care for people living with Primary Immune ...
KOPIE VON: Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZBOne document
Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZBOne document
The development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZBOne document
Ethicon Launches New Powered Circular Stapler With Dual Technologies to Reduce Anastomotic Complications in Colorectal, Gastric, and Thoracic Surgery
Vienna (ots/PRNewswire) - Innovative technology helps address critical challenge of anastomotic leaks which can occur in up to 8.6% of colorectal surgeries1,11% in oesophagectomies2 and 4% in gastrectomies3 Ethicon*, part of the Johnson & Johnson Medical Devices Companies**, today announced the launch of the ECHELON ...
Press Release STADA Delivers Strong First-Half 2019 Results With reported sales growth of 11 percent in the first-half of 2019, STADA is performing well above the industry average. - 11 percent sales growth and a significant 13 percent increase in adjusted EBITDA - growth driven by both the brands/OTC segment and the generics business - Portfolio expansion ...One document
One document One document
Siena, Italy (ots/PRNewswire) - Philogen S.p.A., a privately-owned biotechnology company, today announced through its wholly-owned Swiss subsidiary, Philochem AG, a collaboration agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover new small molecule-based therapeutics utilizing Philochem's novel ...